Supplementary Table 2 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
crossref(2024)
摘要
Supplementary Table 2. Antibodies and dilutions used in Cyclic Immunofluorescence (CyCIF) with vendor, catalogue number, and dilution used for each marker.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要